Miles White, who was Abbotts CEO from 1999 until 2020, remained with the company as executive chairman until the end of 2021. Robert B Ford is the Senior Vice President of Abbott Laboratories. What is the salary of Mr Ford? Mr. Ford owns over 102,425 units of Abbott Laboratories stock worth over $24,730,770 and over the last 9 years he sold ABT stock worth over $2,638,762. Calamari The shares were sold at an average price of $105.10, for a transaction totalling $10,764,867.50. Move Over Lithium 220 Pounds of Graphite In Every EV Battery. Chicago, IL 60601 Most recently he exercised 102,425 units of ABT stock worth $4,121,582 on 25 August 2022. . Over the last 23 years, insiders at Abbott Laboratories have traded over $365,964,884 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 Abbott is also one of the world's top five baby formula vendors, which include Nestle and Danone, according to Bloomberg. On average, Abbott Laboratories executives and independent directors trade stock every 8 days with the average trade being worth of $3,584,478. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. Learn More about Robert B. Ford's net worth. sale Other key executives at Abbott Laboratories include According to the SEC Form 4 filings, Robert B Ford has made a total of of 150,000 shares made by Daniel J Starks All Rights Reserved. and Most recently he sold 40,802 units of ABT stock worth $2,571,750 on 30 January 2018. . Fundamental company data provided by Morningstar, updated daily. [1] He received a bachelor's degree from Boston College and an MBA in business administration from at Berkeley's Haas School of Business. Billions could be poured into exploration companies searching for new U.S. deposits. [2] On average, Robert trades about 5,882 units every 58 days since 2014. Insiders are limited to only officers and/or directors of the company. He assumed the role of Chairman in December 2021, having been appointed President and Chief Executive Officer in March 2020. View saved articles. Mr. Ford earned a bachelor's degree from Boston College and a master's degree in business administration from UC Berkeley, Haas School of Business. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott is a global healthcare leader that helps people live more fully at all stages of life. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. See who is leading new copper discoveries and how. #HealthyReturns" The largest trade he's ever made was exercising 102,425 units of Abbott Laboratories stock on 25 August 2022 worth over $4,121,582. Robert B. Ford is Abbott's Chairman of the Board and Chief Executive Officer. Track performance, allocation, dividends, and risks . You may also find the annual proxy statement by going directly to the company's website. 1 transactions in Abbott Laboratories (ABT) over the past 5 years, including 0 buys and 1 sells. There are 6 executives at Abbott Laboratories getting paid more, . Get notified the next time Robert B. Ford buys or sells Abbott Laboratories stock. As of 25 August 2022 he still owns at least 244,496 units of Abbott Laboratories stock. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Oct 05, 2021, 11:00 ET. The most recent stock trade was executed by Julie L. Tyler on 17 February 2023, trading 260 units of ABT stock currently worth $26,842. Our 109,000 colleagues serve people in more than 160 countries. Following is the unofficial transcript of a CNBC interview with Abbott President & CEO Robert Ford and CNBC's Host of "Mad Money w/ Jim Cramer" & Co-Anchor of "Squawk on the Street" Jim Cramer . GuruFocus also compares Robert B Ford's trading performance to market benchmark return within the same time period. Robert Sengstacke Abbott (December 24, 1870 - February 29, 1940) was an American lawyer, newspaper publisher and editor. Mr. Ford owns 142,071 shares of Abbott Laboratories stock worth more than $14,272,453 as of February 25th. Most recently he exercised 102,425 units of ABT stock worth $4,121,582 on 25 August 2022. . Its portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Robert Ford Net Worth The estimated Net Worth of Robert B Ford is at least Abbott Laboratories stock worth over $5,790,426 and over the . Over the last 23 years, insiders at Abbott Laboratories have traded over $365,964,884 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 RANK89. As the President, Chief Executive Officer, and Director of Abbott Laboratories, the total compensation of Robert Ford at Abbott Laboratories is $11,897,900. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement. Learn More on Robert B. Ford's salary. The most recent insider tranaction occured on February, 22nd when SVP Julie L Tyler sold 260 shares worth more than $26,842.40. Abbott Labs Board Chairman/CEO Robert Ford could hardly have picked a better time for his CES keynote address, the first by a healthcare company representative in CES history. 89. . Gurus may be added or dropped from the GuruFocus site at any time. The most recent stock trade was executed by Julie L. Tyler on 17 February 2023, trading 260 units of ABT stock currently worth $26,842. "Abbott Labs veteran CEO White to step down next March", "Longtime Abbott Labs CEO Miles White to Step Down in March", "Medtech Giant Elects New CEO As 21-Year Veteran Steps Down", "Abbott CEO Miles White to step down in March", "Robert Ford named president, COO of Abbott", "Abbott beats revenue projections as sales outperform previous year", "Abbott CEO Miles D White To Step Down In 2020, Robert B Ford To Take Over", "Incoming Abbott CEO says not looking to do any deals", "Abbott Profits Rise As Covid-19 Diagnostic Sales Eclipse 400 Million Tests", "Abbott Went All In on Covid Tests, And It's Just Getting Started", "CEO of the Week: Abbott Laboratories CEO Robert B. Ford", "Abbott's Miles White retires as executive chairperson", https://en.wikipedia.org/w/index.php?title=Robert_B._Ford&oldid=1136426046, Short description is different from Wikidata, Creative Commons Attribution-ShareAlike License 3.0, This page was last edited on 30 January 2023, at 07:14. Robert Ford, left, and Miles White. Over the last 23 years, insiders at Abbott Laboratories have traded over $365,964,884 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. As the Chairman of Abbott Laboratories, Mr. Ford earned a total compensation package of $24,914,886.00 in 2021. Robert B. Ford is the Chairman, Pres & CEO at Abbott Laboratories. Robert B Ford owns about 339,474 units of Abbott. They sold a total of 345,468 shares worth more than $36,920,834.37. Robert B. Ford Net Worth Mr. Robert B. Ford biography. He subsequently held various positions of increasing responsibility for Abbott's Diagnostics, Nutrition and Diabetes Care businesses. This chart shows Mr. Robert B. Ford's buying and selling at Abbott Laboratories by year and by quarter. Of this total $1,482,692 was received as a salary, $3,168,400 was received as a bonus, $8,689,978 was received in stock options, $8,689,294 was awarded as stock and $129,179 came from other types of compensation. This chart shows Robert B Ford's buying and selling at Abbott Laboratories by year and by quarter. Information on this page was last updated on 2/22/2023. Robert Ford made $20,450,586 in total compensation as Director, Chief Executive Officer and President at Abbott Laboratories in . Most recently he exercised 102,425 units of ABT stock worth $4,121,582 on 25 August 2022. Text size. Abbott Laboratories CEO Robert Ford received a $4.5 million raise last year as the medical device company saw sales surge amid rising demand for its COVID-19 BinaxNOW tests. The corporate mailing address for Mr. Ford and other Abbott Laboratories executives is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. "Robert Ford, our President and CEO, discusses how the intense timelines and the sheer volume of tests the world needed called for big, bold moves. Thorough reviews have been conducted to assure this data accurately reflects disclosures. Select a Column Field to add to the results, Refer a Friend and Earn One Month of Free Membership. Mr. Ford earned a salary of $1,482,692.00, stock awards of $8,689,294.00, options awards of $8,689,978.00, non-equity compensation of $3,168,400.00, and other compensation of $129,179.00. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. She is known for her roles as Corky Sherwood on the CBS sitcom Murphy Brown, for which she received five Primetime Emmy Award nominations, [1] and as Hope Shanowski on the ABC sitcom Hope & Faith . Robert B. Ford serves as President, Chief Executive Officer, Director of the Company. Mr. Ford owns over 102,425 units of Abbott Laboratories stock worth over $25,112,184 and over the last 9 years he sold ABT stock worth over $2,638,762. But he collected the same $1.9 million . The estimated Net Worth of Robert B Ford is at least $39.1 Million dollars as of 25 August 2022. You can see the complete history of Mr. Ford stock trades at the bottom of the page. Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. Markets; Tools Portfolios. Transaction Summary of Robert B Ford The chart on this page features a breakdown of the total annual pay for Robert B. Ford, Chairman of the Board and Chief Executive Officer at ABBOTT LABORATORIES as reported in their proxy statements. . sale 130 E. Randolph St. Investors constantly hear that lithium is the key to powering our transition to electric vehicles and clean energy. Previously, he served as President and Chief Operating Officer; and as Executive Vice President, Medical Devices, leading Abbotts Diabetes Care, Cardiovascular and Neuromodulation businesses. a net Abbott has hit some hurdles in its nutritional products segment since the U.S. Food & Drug Administration and the U.S. Centers for Disease Control & Prevention opened an investigation in February into the companys production of baby powder formulas at a Sturgis, Mich., manufacturing plant. Truth is, switching from gas-powered isn't possible without massive amounts of graphite. [1] He received a bachelor's degree from Boston College and an MBA in business administration from at Berkeley 's Haas School of Business. 102,425 shares on August 25, 2022, which of 799,867 shares. Learn More on Robert B. Ford's contact information. Ford arrived with Abbott having gathered no less than five CES 2022 Innovation Awards and also in the wake of the company's heady 2021 year of achievement, which included FDA approvals for its innovations and, not . of 64,956 shares made by Andrea F Wainer In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. Learn More on Robert B. Ford's contact information. no insider transaction in Abbott Laboratories (ABT). There are no executives at Abbott Laboratories getting paid more. Abbott Laboratories' insider roster includes Hubert Allen (Insider), Roxanne Austin (Director), Roger Bird (SVP), Brian Blaser (Insider), Philip Boudreau (VP), Sharon Bracken (Insider), John Capek (EVP), Jaime Contreras (SVP), Michael Dale (SVP), Lisa Earnhardt (EVP), Robert Ford (Chairman), Robert Ford (CEO), Robert Funck (CFO), Stephen Fussell (EVP), John Ginascol (EVP), Sammy Karam (SVP), Michelle Kumbier (Director), Andrew Lane (EVP), Joseph Manning (SVP), Nancy Mckinstry (Director), Mary Moreland (EVP), Louis Morrone (SVP), Phebe Novakovic (Director), Michael Pederson (SVP), Daniel Salvadori (EVP), Christopher Scoggins (SVP), Daniel Starks (Director), Julie Tyler (SVP), Andrea Wainer (EVP), Jared Watkin (SVP), Miles White (Chairman), Randel Woodgrift (SVP), and Brian Yoor (CFO). and In addition, he makes $11,897,900 as President, Chief Executive Officer, and Director at Abbott Laboratories. Mr. Ford owns over 102,425 units of Abbott Laboratories stock worth over $24,857,908 and over the last 9 years he sold ABT stock worth over $2,638,762. Robert Nottingham. For its 2021 fiscal year, ABBOTT LABORATORIES, listed the following CEO pay ratio data on its annual proxy statement to the SEC. Previously, he served as President and Chief Operating Officer, with responsibility for all of the company's operating businesses; and Executive Vice President, Medical Devices, leading our Diabetes Care, Cardiovascular and Neuromodulation businesses. Robert B. Ford is Abbott's Chairman of the Board and Chief Executive Officer. Campion Murphy. His father's net worth is $70 Million. Above is the net worth, insider trading, and ownership report for Robert B Ford. , sale Is Abbott a Fortune 500 company? He joined Abbott's Diagnostics division in 1996 as a Business Unit Manager in Diabetes Care. Abbott Laboratories executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. [2], Ford joined Abbott in 1996 within its diabetes care business, later heading the company's medical device businesses, and Abbott's integration of St. Jude Medical in 2017, its largest acquisition at the time. Its portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Details can be seen in Robert B Ford's Latest Holdings Summary section. Western countries are now scrambling for stable, renewable energy. Mr. Ford earned a bachelor's degree from Boston College and a master's degree in business administration from UC Berkeley, Haas School of Business. Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. CEO Miles White will retain his title as executive chairman of the board. Robert B Ford is The Most Powerful Women In Chicago Business. , A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. of 118,550 shares made by Salvadori Daniel Gesua Sive Robert B. Ford is an American businessman and the thirteenth chief executive officer at Abbott Laboratories, a publicly-traded medical devices and health care company based in Abbott Park, Illinois. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
Monticello, Ny Bus Station Schedule,
Summary Of Barrington Irving, Pilot And Educator,
Frank Fiala Sammy Gravano,
Articles R
